FTY720 pharmacokinetics in mild to moderate hepatic impairment.
about
Preclinical Metabolism, Pharmacokinetics and In Vivo Analysis of New Blood-Brain-Barrier Penetrant Fingolimod Analogues: FTY720-C2 and FTY720-MitoxyFingolimod: a review of its use in relapsing-remitting multiple sclerosis.Fingolimod for relapsing multiple sclerosis: an update.FTY720 in multiple sclerosis: the emerging evidence of its therapeutic value.FTY720 (fingolimod) for relapsing multiple sclerosis.Fingolimod: a review of its use in the management of relapsing-remitting multiple sclerosis.Clinical pharmacokinetics of fingolimod.Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis.Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort.Population pharmacokinetics of fingolimod phosphate in healthy participants.A mechanistic study to assess whether isoproterenol can reverse the negative chronotropic effect of fingolimod.Fingolimod (FTY720) in severe hepatic impairment: pharmacokinetics and relationship to markers of liver function.
P2860
Q28553993-C7B2CAA1-D782-4D5C-8721-075A494CAC25Q30838717-664F4F29-F6A0-4A1A-B2AB-D3EE439AC755Q34618474-5616BBDB-7644-4C6C-9588-CE53814883D3Q35876398-83C46F0F-8582-4291-9DCC-2DA439BD617EQ37154788-5C399A2C-C808-44F8-88D3-72E65AAC43EBQ37905767-DDBE5CCF-8135-41E7-A5CA-8F86A48BBC0BQ37965580-9C74836B-FAC0-467A-8FB8-66340AE17D88Q38192006-B2B8A4B3-1022-4AAF-A30F-FF4FD9ACEB43Q42655958-6AE08756-8B48-4AF4-9E5F-4C93972BB8CFQ45171971-5828C0F9-0935-4075-A85A-70E793C3865BQ46792453-B25AF47F-F3DB-46E3-BE24-B8D42F190E27Q46908020-E791E1BA-363A-44C1-BE01-96368E17BA16
P2860
FTY720 pharmacokinetics in mild to moderate hepatic impairment.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
FTY720 pharmacokinetics in mild to moderate hepatic impairment.
@en
FTY720 pharmacokinetics in mild to moderate hepatic impairment.
@nl
type
label
FTY720 pharmacokinetics in mild to moderate hepatic impairment.
@en
FTY720 pharmacokinetics in mild to moderate hepatic impairment.
@nl
prefLabel
FTY720 pharmacokinetics in mild to moderate hepatic impairment.
@en
FTY720 pharmacokinetics in mild to moderate hepatic impairment.
@nl
P2093
P2860
P356
P1476
FTY720 pharmacokinetics in mild to moderate hepatic impairment.
@en
P2093
Kovarik JM
Lasseter KC
Schmouder RL
P2860
P304
P356
10.1177/0091270004274288
P577
2005-04-01T00:00:00Z